
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $3.3B | $3.3B | $2.8B | $3.6B | $3.7B | |
Revenue Growth (YoY) | 2.07% | 1% | -13.2% | 25.63% | 2.67% | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $127.8M | $140.5M | -- | -- | -- | |
Other Inc / (Exp) | -$12M | $700K | $54.7M | -$27M | -$11.2M | |
Operating Expenses | $262.4M | $252.2M | $25.5M | $34.4M | $35.9M | |
Operating Income | -- | -- | -- | -- | -- | |
Net Interest Expenses | $44M | $50.8M | $39.7M | $50M | $53.1M | |
EBT. Incl. Unusual Items | -$268.5M | $190.8M | $275.6M | $625.9M | $685.4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $25.2M | $1.3M | $21.7M | -$86.1M | $58.2M | |
Net Income to Company | -$268.5M | $190.8M | $275.6M | $625.9M | $685.4M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$293.7M | $189.5M | $253.9M | $712M | $627.2M | |
Basic EPS (Cont. Ops) | -$1.83 | $1.11 | $1.48 | $4.12 | $3.66 | |
Diluted EPS (Cont. Ops) | -$1.83 | $1.09 | $1.45 | $4.03 | $3.56 | |
Weighted Average Basic Share | $160.3M | $171.3M | $172.1M | $172.7M | $171.1M | |
Weighted Average Diluted Share | $162M | $173.1M | $174.5M | $176.7M | $176.1M | |
EBITDA | -- | -- | -- | -- | -- | |
EBIT | -$224.5M | $241.6M | $315.3M | $675.9M | $738.5M | |
Revenue (Reported) | $3.3B | $3.3B | $2.8B | $3.6B | $3.7B | |
Operating Income (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Adjusted) | -$224.5M | $241.6M | $315.3M | $675.9M | $738.5M |
Period Ending | 2021-07-18 | 2022-07-18 | 2023-07-18 | 2024-07-18 | ||
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | -- | -- | -- | -- | -- | |
Operating Income | -- | -- | -- | -- | -- | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -- | -- | -- | -- | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -- | -- | -- | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -- | -- | -- | |
Basic EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
Weighted Average Basic Share | -- | -- | -- | -- | -- | |
Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
EBITDA | -- | -- | -- | -- | -- | |
EBIT | -- | -- | -- | -- | -- | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Adjusted) | -- | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $3.3B | $3.3B | $2.8B | $3.6B | $3.7B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $127.8M | $140.5M | -- | -- | -- | |
Other Inc / (Exp) | -$12M | $700K | $54.7M | -$27M | -$11.2M | |
Operating Expenses | $262.4M | $252.2M | $25.5M | $34.4M | $35.9M | |
Operating Income | -- | -- | -- | -- | -- | |
Net Interest Expenses | $44M | $50.8M | $39.7M | $50M | $53.1M | |
EBT. Incl. Unusual Items | -$268.5M | $190.8M | $275.6M | $625.9M | $685.4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $25.2M | $1.3M | $21.7M | -$86.1M | $58.2M | |
Net Income to Company | -$268.5M | $190.8M | $275.6M | $625.9M | $685.4M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$293.7M | $189.5M | $253.9M | $712M | $627.2M | |
Basic EPS (Cont. Ops) | -$1.83 | $1.11 | $1.48 | $4.12 | $3.66 | |
Diluted EPS (Cont. Ops) | -$1.83 | $1.09 | $1.45 | $4.03 | $3.56 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -- | -- | -- | -- | -- | |
EBIT | -$224.5M | $241.6M | $315.3M | $675.9M | $738.5M | |
Revenue (Reported) | $3.3B | $3.3B | $2.8B | $3.6B | $3.7B | |
Operating Income (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Adjusted) | -$224.5M | $241.6M | $315.3M | $675.9M | $738.5M |
Period Ending | 2022-07-18 | 2023-07-18 | 2024-07-18 | 2025-07-18 | 2026-07-18 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | -- | -- | -- | -- | -- | |
Operating Income | -- | -- | -- | -- | -- | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -- | -- | -- | -- | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -- | -- | -- | -- | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -- | -- | -- | |
Basic EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
Weighted Average Basic Share | -- | -- | -- | -- | -- | |
Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
EBITDA | -- | -- | -- | -- | -- | |
EBIT | -- | -- | -- | -- | -- | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Adjusted) | -- | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $1.6B | $1.3B | $1.4B | $1.4B | $1.2B | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $1.4B | $155.4M | $160.6M | $206.5M | $249M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $26.9M | -- | -- | -- | -- | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $3.2B | $1.5B | $1.5B | $1.6B | $1.5B | |
Property Plant And Equipment | $109.4M | $90.4M | $133.1M | $132.7M | $126.2M | |
Long-Term Investments | $6.1B | $6B | $5.8B | $6.6B | $7.1B | |
Goodwill | $8.8M | $8.3M | $7.8M | $8.2M | $8.1M | |
Other Intangibles | $290.1M | $304.8M | $312.6M | $315.7M | $300.7M | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | $13.9B | $10.8B | $10.4B | $11.1B | $11.2B | |
Accounts Payable | $1B | $281M | -- | -- | $342.9M | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $1.2B | $302.3M | $32.2M | $30.9M | $40.5M | |
Long-Term Debt | $943.3M | -- | $628.8M | $667M | $656.2M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $11.5B | $8.3B | $7.7B | $7.8B | $7.6B | |
Common Stock | $38.7M | $38.7M | $38.7M | $38.8M | $38.1M | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | $2.4B | $2.6B | $2.6B | $3.3B | $3.7B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $1.1M | $1.1M | $1.1M | $1.1M | $1.1M | |
Total Equity | $2.4B | $2.6B | $2.6B | $3.3B | $3.7B | |
Total Liabilities and Equity | $13.9B | $10.8B | $10.4B | $11.1B | $11.2B | |
Cash and Short Terms | $1.6B | $1.3B | $1.4B | $1.4B | $1.2B | |
Total Debt | $946.1M | -- | $635.9M | $674.4M | $663.5M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $1.6B | $1.3B | $1.4B | $1.4B | $1.2B | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $1.4B | $155.4M | $160.6M | $206.5M | $249M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $26.9M | -- | -- | -- | -- | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $3.2B | $1.5B | $1.5B | $1.6B | $1.5B | |
Property Plant And Equipment | $109.4M | $90.4M | $133.1M | $132.7M | $126.2M | |
Long-Term Investments | $6.1B | $6B | $5.8B | $6.6B | $7.1B | |
Goodwill | $8.8M | $8.3M | $7.8M | $8.2M | $8.1M | |
Other Intangibles | $290.1M | $304.8M | $312.6M | $315.7M | $300.7M | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | $13.9B | $10.8B | $10.4B | $11.1B | $11.2B | |
Accounts Payable | $1B | $281M | -- | -- | $342.9M | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $1.2B | $302.3M | $32.2M | $30.9M | $40.5M | |
Long-Term Debt | $943.3M | -- | $628.8M | $667M | $656.2M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $11.5B | $8.3B | $7.7B | $7.8B | $7.6B | |
Common Stock | $38.7M | $38.7M | $38.7M | $38.8M | $38.1M | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $1.1M | $1.1M | $1.1M | $1.1M | $1.1M | |
Total Equity | $2.4B | $2.6B | $2.6B | $3.3B | $3.7B | |
Total Liabilities and Equity | $13.9B | $10.8B | $10.4B | $11.1B | $11.2B | |
Cash and Short Terms | $1.6B | $1.3B | $1.4B | $1.4B | $1.2B | |
Total Debt | $946.1M | -- | $635.9M | $674.4M | $663.5M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$268.5M | $190.8M | $275.6M | $625.9M | $685.4M | |
Depreciation & Amoritzation | $56.8M | $58.3M | $60M | $77.1M | $60.7M | |
Stock-Based Compensation | $10.3M | $24M | $27.2M | $43.2M | $49.1M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$117.1M | $16.6M | $373.4M | $232.1M | $114.4M | |
Capital Expenditures | $71.5M | $58.9M | $82.8M | $43.7M | $39.1M | |
Cash Acquisitions | -- | $21.4M | -- | $9.5M | $500K | |
Cash From Investing | -$52.7M | -$36.6M | -$81.9M | -$34.2M | -$38.5M | |
Dividends Paid (Ex Special Dividend) | -- | -$39.2M | -$119.8M | -$124.5M | -$127M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $470M | -- | $279.1M | -- | -- | |
Long-Term Debt Repaid | -$289.4M | -$195.7M | -$336.6M | -- | -- | |
Repurchase of Common Stock | -$23.9M | -- | -- | -- | -$149.1M | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | $592.8M | -$246.2M | -$190.9M | -$128.9M | -$282.6M | |
Beginning Cash (CF) | $1.1B | $1.6B | $1.3B | $1.4B | $1.4B | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $423M | -$266.2M | $100.6M | $69M | -$206.7M | |
Ending Cash (CF) | $1.6B | $1.3B | $1.4B | $1.4B | $1.2B | |
Levered Free Cash Flow | -$188.6M | -$42.3M | $290.6M | $188.4M | $75.3M |
Period Ending | 2021-07-18 | 2022-07-18 | 2023-07-18 | 2024-07-18 | ||
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -- | -- | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -- | -- | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | -- | -- | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | -- | -- | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$268.5M | $190.8M | $275.6M | $625.9M | $685.4M | |
Depreciation & Amoritzation | $56.8M | $58.3M | $60M | $77.1M | $60.7M | |
Stock-Based Compensation | $10.3M | $24M | $27.2M | $43.2M | $49.1M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$117.1M | $16.6M | $373.4M | $232.1M | $114.4M | |
Capital Expenditures | $71.5M | $58.9M | $82.8M | $43.7M | $39.1M | |
Cash Acquisitions | -- | $21.4M | -- | -- | -- | |
Cash From Investing | -$52.7M | -$36.6M | -$81.9M | -$34.2M | -$38.5M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -$119.8M | -$124.5M | -$127M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $470M | -- | $279.1M | -- | -- | |
Long-Term Debt Repaid | -$289.4M | -$195.7M | -$336.6M | -- | -- | |
Repurchase of Common Stock | -$23.9M | -- | -- | -- | -$149.1M | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | $592.8M | -$246.2M | -$190.9M | -$128.9M | -$282.6M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $490M | -$280.1M | $101.5M | $69.3M | -$205.6M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$188.6M | -$42.3M | $290.6M | $188.4M | $75.3M |
Period Ending | 2022-07-18 | 2023-07-18 | 2024-07-18 | 2025-07-18 | 2026-07-18 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -- | -- | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -- | -- | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | -- | -- | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | -- | -- | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | -- | -- | -- |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.